DA: Årets vindere og tabere på det danske aktiemarked

Året 2024 har været svært for de danske aktier, men der har også været lyspunkter. Samlet set var aktiemarkedet i Danmark præget af tab for nogle store selskaber, mens mindre firmaer havde stor succes.

Vindere og tabere på aktiemarkedet i 2024

Tabere

• Vestas havde et meget hårdt år med et fald på over 54 %. Årsagen var blandt andet skuffende indtjening og forsinkelser i grønne projekter.

• Novo Nordisk faldt cirka 10 %, blandt andet fordi deres nye vægttabsmedicin ikke klarede sig så godt som forventet.

• Det danske aktiemarked blev også påvirket negativt af USA’s præsidentvalg, hvor aktiekurserne faldt med 10-12 % på selve valgdagen. Usikkerhed omkring fremtidige toldafgifter bidrog til nedgangen.

Vindere

• Harboe steg med mere end 93 %, og biotekselskabet Gubra steg hele 399 %, hvilket var årets højeste stigning i Danmark.

• Mindre selskaber klarede sig generelt godt, især inden for bioteknologi.

Sammenligning med Europa og USA

• Selvom danske aktier samlet set klarede sig dårligt, præsterede de på niveau med andre europæiske aktier.

• I USA havde de store teknologiselskaber som Nvidia, Apple og Tesla et rigtig godt år med store stigninger. Den amerikanske techsektor var en af de største vindere i 2024.

Forventninger til 2025

Aktieeksperten Jacob Pedersen forventer et bedre år for danske aktier i 2025. Han mener, at mange danske selskaber er godt rustet til en global økonomi med moderat vækst. Det kan betyde færre skuffelser og måske et bedre samlet resultat næste år.

Kort sagt: 2024 var blandet for danske aktier, men der er optimisme for 2025.

Kilde: dr.dk

ENG: This year's winners and losers on the Danish stock market

The year 2024 has been difficult for Danish shares, but there have also been bright spots. Overall, the stock market in Denmark was characterized by losses for some large companies, while smaller companies were very successful.

Stock market winners and losers in 2024

Losers

• Vestas had a very tough year with a fall of over 54%. The reason was, among other things, disappointing earnings and delays in green projects.

• Novo Nordisk fell approximately 10%, partly because their new weight loss drug did not perform as well as expected.

• The Danish stock market was also negatively affected by the US presidential election, with share prices falling by 10-12% on election day itself. Uncertainty about future customs duties contributed to the decline.

Winners

• Harboe rose by more than 93%, and biotech company Gubra rose a whopping 399%, which was the highest increase of the year in Denmark.

• Smaller companies generally performed well, particularly in biotechnology.

Comparison with Europe and the USA

• Although Danish stocks performed poorly overall, they performed on par with other European stocks.

• In the USA, the major technology companies such as Nvidia, Apple and Tesla had a very good year with large increases. The US tech sector was one of the biggest winners in 2024.

Expectations for 2025

Equity expert Jacob Pedersen expects a better year for Danish shares in 2025. He believes that many Danish companies are well equipped for a global economy with moderate growth. This could mean fewer disappointments and perhaps a better overall result next year.

In short: 2024 was mixed for Danish shares, but there is optimism for 2025.